245 related articles for article (PubMed ID: 7043677)
1. [Endocrinological aspects of fibrocystic mastopathy].
Angelia A; Dogliotti L; Borretta G; Violino PL
Recenti Prog Med; 1982 Jan; 72(1):31-64. PubMed ID: 7043677
[No Abstract] [Full Text] [Related]
2. Benign breast disease.
Mauvais-Jarvis P; Kuttenn F
Curr Ther Endocrinol Metab; 1994; 5():364-70. PubMed ID: 7704754
[No Abstract] [Full Text] [Related]
3. [Functional state of the thyroid gland in fibrocystic mastopathy].
Sturua NT
Sov Med; 1982; (9):103-4. PubMed ID: 7147058
[No Abstract] [Full Text] [Related]
4. [Effect of parlodel and thyroliberin on prolactin secretion in patients with fibrocystic mastopathy].
Sturia NT
Probl Endokrinol (Mosk); 1983; 29(2):21-4. PubMed ID: 6406998
[TBL] [Abstract][Full Text] [Related]
5. [Fibrocystic mastopathy and cancer of the breast. About 111 cases].
Beyrouti MI; Beyrouti R; Khabir A; Ben Amar M; Frikha F; Dhieb N; Damak D; Abid M; Affes N; Boujelben S; Frikha M
Tunis Med; 2006 Oct; 84(10):626-31. PubMed ID: 17193854
[TBL] [Abstract][Full Text] [Related]
6. [Endocrinology and therapy of breast diseases].
Breckwoldt M
Zentralbl Gynakol; 1990; 112(17):1097-9. PubMed ID: 2264419
[TBL] [Abstract][Full Text] [Related]
7. [Hormone treatment of benign breast diseases].
Mauvais-Jarvis P
Bull Cancer; 1991; 78(4):365-71. PubMed ID: 1859904
[No Abstract] [Full Text] [Related]
8. Fibrocystic breast disease: pathophysiology, pathomorphology, clinical picture, and management.
Vorherr H
Am J Obstet Gynecol; 1986 Jan; 154(1):161-79. PubMed ID: 3511705
[TBL] [Abstract][Full Text] [Related]
9. [Clinical aspects of breast disease. Current status of diagnosis and therapy].
Peters F
Zentralbl Chir; 1992; 117(4):191-206. PubMed ID: 1318629
[No Abstract] [Full Text] [Related]
10. Serum androgen levels and the menstrual cycle in women with benign or malignant breast disease.
England PC; Sellwood RA; Knyba RE; Irvine JD
Clin Oncol; 1981 Sep; 7(3):213-9. PubMed ID: 6211319
[No Abstract] [Full Text] [Related]
11. [Mastodynia and fibrocystic disease of the breast. Perspectives and methods of medical treatment].
van Bogaert LJ
J Gynecol Obstet Biol Reprod (Paris); 1986; 15(6):805-11. PubMed ID: 3794218
[TBL] [Abstract][Full Text] [Related]
12. Aspects of fibrocystic disease of the breast. Treatment with danazol.
Humphrey LJ; Estes NC
Postgrad Med J; 1979; 55 Suppl 5():48-51. PubMed ID: 395520
[TBL] [Abstract][Full Text] [Related]
13. [Complex diagnosis of various forms of diffuse mastopathy].
Bukhteeva NF; Zolotarevskiĭ VB; Zal'tsman IN; Zavrazhina IN
Sov Med; 1983; (4):104-9. PubMed ID: 6867822
[No Abstract] [Full Text] [Related]
14. [Fibrocystic mastopathy. Physiopathology, clinical manifestations and therapy].
Natoli A; Liguori M; Visalli N; Paggi A; Marino O; Costa C
Clin Ter; 1986 Nov; 119(4):305-21. PubMed ID: 3542349
[No Abstract] [Full Text] [Related]
15. [Treatment of fibrocystic mastopathy with danazol (100mg/day) studied by thermo-echo-clinical examination].
Dambrosio F; Dibisceglia G; Colombo A
Ann Ostet Ginecol Med Perinat; 1989; Spec No():44-57. PubMed ID: 2672980
[No Abstract] [Full Text] [Related]
16. Fibrocystic breast disease.
Scott EB
Am Fam Physician; 1987 Oct; 36(4):119-26. PubMed ID: 3314435
[TBL] [Abstract][Full Text] [Related]
17. The role of estrogens in mastopathy and mammary cancer in perimenopausal women.
Greenblatt RB; Vasquez J; Samaras C; Nezhat C
J Am Geriatr Soc; 1982 Mar; 30(3):165-9. PubMed ID: 7061788
[TBL] [Abstract][Full Text] [Related]
18. [Therapeutic aspects of mammary dysplasia with antiestrogens].
Baracat FF; Pontes MD; Rodrigues de Lima G
Rev Paul Med; 1982; 100(3):28-9. PubMed ID: 7184117
[No Abstract] [Full Text] [Related]
19. Fibrocystic disease of the breast.
Greenblatt RB; Samaras C; Vasquez JM; Nezhat C
Clin Obstet Gynecol; 1982 Jun; 25(2):365-71. PubMed ID: 7105513
[TBL] [Abstract][Full Text] [Related]
20. [Hormonal disorders in mastopathy and their correction (a review of the literature)].
Filatov AA
Sov Med; 1978 Jun; (6):107-10. PubMed ID: 354023
[No Abstract] [Full Text] [Related]
[Next] [New Search]
